Britain changes vaccine rollout measures for COVID and flu

Marco Green
October 17, 2020

CEO Albert Bourla said Pfizer may know by the end of October whether its shots are effective, depending on how many coronavirus cases appear during late-stage trials. That dims any lingering expectation that there could be a vaccine by Election Day, as President Trump has asserted. Trials for a vaccine produced by AstraZeneca remain frozen by the Food and Drug Administration after a neurological issue was discovered in a trial participant in the UK.

The CDC anticipates that up to 700 million doses of vaccine will be available in April of 2021, enough to vaccinate all Americans because most vaccines in development require two doses per person. "While there is work to be done, the submission of this document represents a positive step forward".

The World Health Organization's (WHO Geneva, Switzerland) chief scientist, Dr. Soumya Swaminathan, has warned that young and healthy people should be prepared to wait for immunization for well over a year. "Vaccines will arrive in dribs and drabs".

The United States has not joined the programme, meaning that the USA timeline for vaccine distribution may differ from the one laid out by the WHO. For instance, some vaccine candidates need cold storage and two doses.

"Right now, our model, our best case, predicts that we will have an answer by the end of October", Bourla previously said on the "Today" show.

The letter was welcomed by Eric Topol, a physician-scientist at Scripps Research Translational Institute who joined other experts in sending a letter to Bourla in late September, asking the company not to seek authorization for a vaccine before late November. What's more, "from the contact tracing reports from various municipalities and states, the worry is that the spread is driven now, by indoor social gatherings in people's homes", he added, as the focus of social life shifts from public to private spaces in the colder weather. The pandemic has sickened more than 5,800 people in ME and claimed 145 lives. Other groups, such as seniors and people with serious chronic medical conditions, have also been disproportionately affected.

As countries worldwide work to establish guidelines about prioritizing who gets the vaccine and when, healthcare officials said that the most vulnerable groups and those at the highest risk of getting sick from COVID-19 should be first in line.

People providing essential services such as health care and education should be among the first to be vaccinated, he said. Whichever version is approved will affect Maine's plan, and who will receive the vaccine first.

Use the form below to reset your password.

Other reports by Click Lancashire

Discuss This Article